Manisha Pandey — ASN Events
  1. Schedule
  2. Manisha Pandey

Manisha Pandey

Griffith University, QLD, Australia

  • This delegate is presenting an abstract at this event.
Associate Professor Manisha Pandey, is a Pricipal Research Fellow and Research Leader at the Institute for Glycomics, Griffith University. Asso Prof Pandey is an Immunologist and a lead researcher in the area of streptococcal vaccine development. Asso Prof Pandey has been leading Streptococcal vaccine research for over 15 years and more recently for SARS-CoV2. She have successfully led several projects from dissecting immunity to infection to the designing and assessment of vaccine candidates. Asso Prof Pandey has successfully led the translation of Strep A vaccine candidates into a pilot study in humans and as a co-investigator on an NHMRC grant, contributed to the development of a human pharyngitis model. As a Principal Scientific Investigator, Asso Prof Pandey has been leading the translation of preclinical studies into a human phase I trial of Strep A vaccines in Australia and Canada.
Presentations this author is a contributor to:

Low-dose interleukin-2 therapy: A transformative approach for the management of autoimmune complications associated with Streptococcus pyogenes infections (117139)

11:32 AM
Ailin Lepletier
Plenary 2 - New Insights and New Tools

Developing a Next-Generation Vaccination Strategy Leveraging Traditional Approaches to Combat Streptococcus pyogenes (StrepA) Infections (#188)

5:30 PM
Manisha Pandey
Poster Session 1

Parenteral vaccination with a super immunogen targeting M-protein provides unprecedented protection against group A streptococcus (StrepA) respiratory infections (#187)

5:30 PM
Victoria Ozberk
Poster Session 1

Delineating Humoral and Cellular Immune Responses Induced by a Peptide-Based Vaccine for Protection Against Streptococcus pyogenes (#293)

5:30 PM
Despena Vedis
Poster Session 2

Phase I Trial of a Peptide-based Vaccine to Prevent Group A Streptococcal Infection (118111)

9:15 AM
Michael F. Good
Plenary 5 - Interventions for Prevention

The longitudinal characterisation of immune responses in the Rat Autoimmune Valvulitis model enables the assessment of disease severity and the identification of biomarkers for ARF/RHD screening (#224)

5:30 PM
Rukshan Ahamed Mohamed Rafeek
Poster Session 2

Human antibodies to M-protein epitope-based vaccines demonstrate binding to Streptococcus pyogenes (StrepA) and bactericidal activity (#290)

5:30 PM
Christie T M Short
Poster Session 2